newsfilter
← Latest News
GlobeNewswire·

Vallon Pharmaceuticals Provides Update on Recent Pipeline and Corporate Advancements

- Lead program, ADAIR, advancing toward completion of patient enrollment and treatment in ongoing SEAL study - Selection of final formulation completed for second development program, ADMIR - Company's two lead programs targeting the large